AnPac Bio-Medical Science

General Information


We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented CDA technology and our proprietary CDA device. In addition to early cancer screening and detection, our CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.

Employees: 101
Founded: 2010
Contact Information
Address 801 Bixing Street, Bihu County Lishui, Zhejiang Province 323006, People’s Republic of China
Phone Number +86-578-2051-6666
Web Address
View Prospectus: AnPac Bio-Medical Science
Financial Information
Market Cap $134.4mil
Revenues $1.6 mil (last 12 months)
Net Income $-11.3 mil (last 12 months)
IPO Profile
Symbol ANPC
Exchange NASDAQ
Shares (millions): 1.3
Price range $12.00 - $12.00
Est. $ Volume $16.0 mil
Manager / Joint Managers WestPark Capital/ Univest Securities
CO-Managers -
Expected To Trade: 1/30/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change